Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2010
04/08/2010US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
04/08/2010US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents
04/08/2010US20100087320 Arylphenyl-substituted cyclic keto-enols
04/08/2010US20100086482 Divergent synthesis of looped poly(ester)-and poly(ether)-substituted dendrons and dendrimers
04/08/2010CA2738663A1 Spiro-imidazolone derivatives as glucagon receptor antagonists
04/07/2010EP2170900A1 Crystalline form ii of 7-(dimethoxy-methyl) camptothecin, its use as intermediate and products obtained therefrom
04/07/2010EP2170899A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
04/07/2010EP2170879A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
04/07/2010EP2170807A1 Spiro compounds useful as antagonists of the h1 receptor
04/07/2010EP1551829B1 Novel compounds with antibacterial activity
04/07/2010CN101691375A Preparation method of intermediate used for synthesizing cephalotaxin
04/07/2010CN101190918B Microwave hydrolysis method for using pyrano[3,2-g]quinolin-2,8-diformic acid ester derivative to prepare dicarboxylic acid of the same
04/06/2010US7692014 Inhibitors of the HIV integrase enzyme
04/06/2010US7692011 8-hydroxy and 8-mercapto quinazolinones
04/06/2010US7691896 7,8-Dihydrosalinosporamide; inhibiting proteasome inhibiting proteasome; ischemic or reperfusion injury; cancer
04/06/2010US7691869 Pyrrolotriazolopyrimidine derivatives, pharmaceutical compositions containing them and methods of treating conditions and diseases mediated by the adenosine A2A receptor activity
04/06/2010US7691868 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010CA2437702C Method of synthesizing camptothecin-relating compounds
04/06/2010CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/01/2010WO2010034790A1 Protease inhibitors
04/01/2010WO2010034789A1 Protease inhibitors
04/01/2010WO2010034788A1 Protease inhibitors
04/01/2010WO2010034243A1 Novel gene cluster
04/01/2010WO2009148654A3 Cephalotaxus esters, methods of synthesis, and uses thereof
04/01/2010US20100081822 Method of purifying crude noscapine
04/01/2010US20100081808 Process for production of optically active epoxy compound
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081651 R(-)-11-hydroxyaporphine derivatives and uses thereof
04/01/2010US20100081650 Antimicrobial Compounds
04/01/2010CA2738025A1 Protease inhibitors
04/01/2010CA2738023A1 Protease inhibitors
03/2010
03/31/2010EP2168962A2 Phenylacetamides and their use as glucokinase modulators
03/31/2010EP2167507A1 Cysteine protease inhibitors
03/31/2010EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
03/31/2010EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
03/31/2010EP2167196A1 Heterocyclic compounds for the treatment of tuberculosis
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010CN101687881A Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
03/31/2010CN101687880A Cysteine protease inhibitors
03/31/2010CN101687879A 5-furopyridinone substituted indazoles
03/31/2010CN101687878A Catecholamine derivatives useful for the treatment of parkinson' s disease
03/31/2010CN101687877A Heterocyclic cyclopamine analogs and methods of use thereof
03/31/2010CN101687869A Heterocyclic compounds useful as MK2 inhibitors
03/31/2010CN101687865A A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
03/31/2010CN101687864A 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors
03/31/2010CN100596297C Technology for extracting dihydrogalanthamine from lycoris radiata genus plant
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687628 Method of preparing 4-amino-1H-imidazo(4,5-c)quinolines and acid addition salts thereof
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687487 Prodrug, hydrate, solvate, polymorph, tautomer; conjugate with Fluropyrimidine; Pyrimidine Nucleoside; Purine Nucleoside; Antifolate, Platinum Analog; Anthracycline, Anthracenedione; tablet, suspension, solution, gelatin capsule; injection, infusion pump, suppository, retention enema; cancers
03/30/2010US7687086 Method for obtaining taxanes
03/30/2010CA2450961C Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
03/30/2010CA2364705C Optically pure camptothecin analogues
03/25/2010WO2010033701A2 Inhibitors of sphingosine kinase 1
03/25/2010US20100076190 Method for synthesis of nitroxyl radical
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076012 Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
03/25/2010US20100076005 Isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/24/2010EP2166012A1 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
03/24/2010CN101679450A Process for making topotecan
03/24/2010CN101679449A Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101676258A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
03/24/2010CN100595195C Preparation method and application of isoquinoline componds and salts thereof
03/23/2010US7683171 N,1-Dimethyl-7-phenyl-1H-imidazo[4,5-d]thieno[3,2-b]pyridin-4-amine; treating inflammatory and immune diseases; cancer; I kappa B kinase (IKK) inhibitors
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010US7683050 Anticancer agents; parasiticides, viricides, fungicides, bactericides; sealed container consisting of an aqueous solution of homoharringtonine (4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl) (HHT), wherein solution is free of pharmaceutical excipients and said sealed container is an ampule or vial
03/18/2010WO2010031054A1 Compositions and methods for treating epilepsy
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010030538A2 Compounds for the treatment of hepatitis c
03/18/2010WO2010029904A1 Method for producing n-substituted-trans-4-azidopiperidine-3-ol
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069380 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof
03/18/2010US20100069374 Tricyclic benzopyrane compound
03/18/2010US20100069371 Thienopyridine and furopyridine kinase inhibitors
03/18/2010US20100069341 Tetrahydro-pyranopyrazole cannabinoid modulators
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP1701960B1 Cysteine protease inhibitors
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010CN101675054A Cyclopamine lactam analogs and methods of use thereof
03/17/2010CN101675053A Phosphoinositide 3-kinase inhibitor compounds and methods of use
03/17/2010CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/16/2010US7678904 or to treat autoimmune and inflammatory disorders; improved water solubility characteristics
03/16/2010CA2510519C Condensed furan compounds
03/11/2010WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
03/11/2010WO2009128964A3 Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase
03/11/2010US20100063289 Method for producing ammonium hexafluorophosphates
03/11/2010US20100063084 Multi-phase release methscopolamine compositions
03/11/2010US20100063083 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer
03/11/2010US20100063068 Compounds for the Treatment of Hepatitis C
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 298